/ /

  • linkedin
  • Increase Font
  • Sharebar

    Formula for achieving successful multifocal IOL outcomes

     

    Because accurate correction of refractive error is key for good visual outcomes with multifocal diffractive bifocal and trifocal IOLs, Dr. Rocha said she uses intraoperative aberrometry to check IOL power and toric IOL alignment.

    Figure 3: Intraoperative correction of astigmatism with a toric extended-depth-of-focus IOL guided by intraoperative aberrometry.

    In order to reduce astigmatism, intraoperative correction with limbal relaxing incisions is planned in some cases. Depending on the amount of pre-existing astigmatism, some patients may be told they will need a combined-staged procedure with postoperative laser vision correction.

     

    Functionality of IOLs

    Understanding the functional outcomes associated with the different multifocal IOLs is also critical so the technology can be matched to the patient’s visual needs. However, surgeons should understand that information obtained from optical bench testing may not translate to the real-life situation.

    “Studies using a single wavelength (green light) at one spatial frequency are not necessarily achieved in vivo,” Dr. Rocha said. “Ideally, IOLs should also be analyzed under white light and multiple spatial frequencies.” Figure 4: Astigmatism management: femtosecond laser limbal relaxing incisions and a combined staged procedure with postoperative laser vision correction.

    Dr. Rocha noted that extended-depth-of-focus (EDOF) IOLs (Tecnis Symfony/Symfony Toric, Abbott Medical Optics) represent a new category of presbyopia-correcting IOLs available in the United States. This technology improves intermediate visual performance and near vision to a lesser extent without comprising distance vision.

    The EDOF technology has the benefit of causing less glare and halos and less loss of contrast, especially compared to the first generation diffractive multifocal IOLs.

    Looking ahead, Dr. Rocha said increased use of in vivo simulation, allowing patients to experience multifocality and compare different IOL designs, will become an important and useful component of the preoperative evaluation.

    “This type of simulation is emerging in adaptive optics technologies that are friendly for use in the clinical situation,” Dr. Rocha said. “It should lead to increased confidence for patients and surgeons when choosing an IOL. It might also increase the number of multifocal IOL procedures performed along with overall patient satisfaction.”

     

    Karolinne M. Rocha, MD, PhD

    E: [email protected]

    This article is based on a presentation given by Dr. Rocha at the 2016 Refractive Surgery Subspecialty Day meeting, prior to the American Academy of Ophthalmology meeting. Dr. Rocha is a consultant/advisor for Johnson & Johnson Vision Care (Abbott Medical Optics), Alcon Laboratories, Allergan, and Bausch + Lomb.

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results